ArticleAnnals of transplantation2026
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy After Liver Transplantation.
Article in Annals of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Liver transplantation in critically ill patients with advanced cirrhosis frequently leads to prolonged ventilation. Percutaneous dilatational tracheostomy is widely used to facilitate weaning, yet the optimal timing after liver transplantation remains uncertain. MATERIAL AND METHODS This retrospective single-center study analyzed 83 of 1352 liver transplant recipients (6.1%) who underwent percutaneous dilatational tracheostomy between December 2010 and June 2024. Patients were retrospectively categorized as early (≤7 days) or late (≥8 days) according to the interval from liver transplantation to tracheostomy. Clinical and laboratory parameters were assessed using group comparisons, multivariable linear regression (with and without log-transformed outcomes), Cox regression, and Kaplan-Meier survival analysis. RESULTS Patients who underwent early percutaneous dilatational tracheostomy had lower platelet counts (57 vs 97×109/L; P=0.047) and higher aspartate aminotransferase (72 vs 46 U/L; P=0.022), alanine aminotransferase (249 vs 67 U/L; P<0.001), and creatinine levels (175 vs 141 μmol/L; P=0.033). Early percutaneous dilatational tracheostomy was independently associated with a shorter intensive care unit stay (ß=-0.651; 95% CI, -1.087 to -0.214; P=0.004; 47.8% reduction) and shorter mechanical ventilation duration (ß=-0.560; 95% CI, -1.027 to -0.093; P=0.020; 42.9% reduction). No significant survival difference was found between early and late percutaneous dilatational tracheostomy (Cox hazard ratio, 0.76; 95% CI, 0.41-1.40; P=0.37). CONCLUSIONS Early percutaneous dilatational tracheostomy was associated with reduced intensive care unit and ventilation times but did not confer a survival benefit. These findings should be interpreted cautiously, given the retrospective single-center design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.